The 11 analysts offering 12-month price forecasts for Pacira Biosciences Inc have a median target of 83.00, with a high estimate of 94.00 and a low estimate of 54.00. The median estimate represents a +44.55% increase from the last price of 57.42.
The current consensus among 11 polled investment analysts is to Buy stock in Pacira Biosciences Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.86
Reporting Date Aug 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.